Cobram Estate $CBO $CBO.AX is Australia’s largest olive oil producer, set to IPO tomorrow on 11 August 2021.
A market leader in a growing industry, here are five reasons I won’t be chasing this IPO.
Let’s take a deep dive.👇
For some context, Australia is a minor producer of olive oil compared to the undisputed global champions in southern Europe.
Much of the industry is fragmented, with nonnas having a few hectares of olive groves, though there are a couple of larger players.
1. The total market is growing at an anemic rate of 1% CAGR. While Aus 🇦🇺 and the US 🇺🇸 is higher around ~3%, it doesn’t pass my “baked beans CAGR” benchmark of 4%.
If the market is growing slower than baked beans, then the bet is more about taking market share. 🥫
2. Increased global competition and changing consumer habits is driving down margins.
While Moro is only 24% of value, it’s 31% of volume. Conversely Cobram is 35% of value, but only 30% of volume.
Another way you see this expressed is the increasing proportion of sales going through lower-margin channels, such as Red Island (less premium version of Cobram Estate) and private labels (supermarket’s own brands).
3. With current margins, normalised FCF may actually be negative – at the least, it’s very fragile.
Total expenses has been greater than sales revenue in FY19, FY20, and breakeven in FY21f (due to abnormally cheap water and lower marketing costs – neither are sustainable).
🚨Indeed the prospectus also includes adjustments in fair values (asset price changes) as revenue – this obviously doesn’t show up in the cash flow statement, and is the basis of their statutory profits. 🚨
And here is the cash flow statement. To be fair to Cobram, they have been investing in the US which has eaten up part of their cash flow, but also worthwhile noting that cash flow from operations is at cyclical highs (high production every two years, low water costs in FY20).
4. Over the long term, they haven’t accumulated significant amounts of net equity or retained earnings.
🚨The prospectus provides a long history of the company and production, but not the financial statements. 🚨
In fact, their net tangible assets is ~$150m (PPE less debt).
This probably sets the floor of what the company may trade at (40c per share, $150m/387m shares outstanding). I suspect the IPO will be significantly higher than this, meaning it will not be an asymmetric bet.
5. Finally, if a prospectus has disingenuous information, that’s a red flag for me.
Repeatedly they claim to be efficient producers, but they don’t provide their actual cost of production figures. 🤷
Moreover, they claim they “8.9x more olive oil per hectare” – though they use intensive irrigated horticulture and are comparing to largely dryland cropping. Using a per hectare measure is dubious, and they should be presenting cost per tonne produced.
To labour the point, Cobram have ~155 trees/hectare, while traditional dryland is ~100. Irrigation is expensive and can cause salinity in the Murray Darling, while Nonna prolly has 0% WACC.
Without knowing the cost of production in a commodity market, one is investing blind.
Update: I listened to their presentation, and they did discuss their efficiencies as '30% lower cost of production to weighted average industry costs' which was useful.
They also noted US will be ~5% of Aus production once trees mature, not a huge growth runway.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Huon $HUO $HUO.AX is the #2 salmon aquaculture business on the #ASX, and is in the midst of a takeover bid from Brazilian JBS at a 38% premium to it's recent price.
So, what does this mean for Tassal $TGR $TGR.AX, the #1 salmon aquaculture business?
Let's take a look.👇
Huon was a turnaround / asset play. The turnaround thesis is that they could improve their operating margins and FCF on what was once a great business; the asset thesis is that you can't readily get licenses for salmon aquaculture anymore. Timing was never certain..
The bid from JBS $JBSAY unleashes all that value for Huon shareholders today - including the Bender family that owns ~53% of the stock and is behind the 'strategic review'.
For good reason, folks are looking for inflation-proof yield-generating real assets. Agricultural land and primary industries are definitely in the spot light, and Rural Funds $RFF.AX $RFF has been on a tear.
But did you know your dividends will be unfranked and grossed down?👇
Before we get into divvies, a quick plug to a previous post on agricultural land, inflation and real asset plays on the #ASX 👇
1.Investment thesis: A fast growing company; operating in a growing industry; a fragmented market with lots of potential for roll-ups; horizontal and vertical integration opportunities; aggressive management.
2.Healthia’s business model is a roll-up platform operating across allied health. Put simply, they want to acquire smaller “mum and dad” businesses to expand their geographic footprint, as well as expand into new areas of healthcare.
Midway $MWY $MWY.AX is a cyclical play on export soft woodchips. Today it's just a brief update on the market conditions, what to expect in the upcoming report - and why I increased my holdings.
Midway provided guidance of $17-19m statutory earnings, and it's going to be at the low end.
This included improving operating conditions in 2H21 and some statutory tailwinds.
Main reason for the lower end of guidance is that a Brisbane shipment was meant to go in June (FY21) but was pushed back to July (FY22) - and it's 36,000tonnes of wood worth ~$2.5m. You can see it in Graincorps $GNC STEM. In the big scheme, this doesn't matter, but good to know.
Sonic Health $SHL $SHL.AX is Australia’s largest listed imaging and diagnostics healthcare company that’s taken on the world. Will this stalwart continue its Covid-sponsored run?
Let’s take a deep dive! 👇
1. Investment Thesis: A stalwart; with Covid and long-term tailwinds; good management; runway for organic and acquisitive growth in a still fragmented market; and historically a decent safe dividend yield.
2. Full disclosure, I first owned Sonic in 2010, and sold in 2015. It kept running, but not very fast. I considered in mid 2020 buying at $26, but anchor bias made me think $22 from March 2020 was better and I sat on the sidelines!